By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Biology - Science Briefing

Biology

Science Briefing

Last updated: May 14, 2026 7:05 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE
[SUBJECT here]
Lactylated NAT10 Drives Cuproptosis in Colorectal Cancer

Key Highlights

Biology · Cell Biology

A new study reveals that lactylated NAT10 promotes cuproptosis, a form of programmed cell death, in colorectal cancer (CRC) cells through a positive feedback loop involving the NAT10/ac4C-DLAT-mRNA/DLAT axis. Researchers demonstrated that elevated copper levels in CRC tissues correlate with increased DLAT expression, and that the process is triggered by the drug elesclomol. This finding is significant for your interests in mechanisms of programmed cell death, such as apoptosis and autophagy, and their implications for tissue disruption and fertility, as it describes a distinct cell death pathway that may be relevant to understanding disease progression and potential therapeutic targets in various tissues, including those involved in reproductive health and aging.

Novelty: 87%

Rigor: 82%

Significance: 88%

Validity: 79%

Clarity: 85%


Read the paper →



Update Your Briefing Preferences

Stay curious. Stay informed —

Science Briefing

Your briefing is personalized based on your selected fields, keywords, and research interests.

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Science Briefing
Next Article Science Briefing
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

How a Cellular Architect Switches Actin Assembly to Remodel Membranes

Today’s Immunology Science Briefing | April 5th 2026, 9:00:31 am

Today’s Cell Biology Science Briefing | March 26th 2026, 1:00:12 pm

Unlocking the Dynamic Disorder of a Key Cancer Suppressor

The Left Ear’s Secret: Auricular Vagus Nerve Stimulation Modulates Immunity in Fibromyalgia

A new frontier in HIV persistence of Biology today

Today’s Cell Biology Science Briefing | April 29th 2026, 9:00:12 am

A new cellular brake on retinal degeneration

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?